Retinal neovascularization, unspecified, unspecified eye. 2016 2017 2018 2019 2020 2021 Billable/Specific Code. H35.059 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2021 edition of ICD-10-CM H35.059 became effective on October 1, 2020. This is the American ICD-10-CM version of ...
ICD-10 Diagnosis Code for Neovascular Glaucoma. Answer: According to Gordon Johns, MD, author of ICD-10-CM for Ophthalmology, either code is appropriate. If you look at 365.63 Glaucoma associated with vascular disorder in the GEM cross walk it takes you to H40.89. This would be the biggest argument that the H40.89 would be the best code to use.
Defining inactive CNV (H35.2x2) and inactive scar (H35.2x3) in wet AMD. For the purpose of these ICD-10 codes, the Academy defines inactive CNV as the absence of IRF or SRF. However, the same eye can have active CNV after the diagnosis of inactive CNV, and treatment can be considered at the time of active CNV.
The CNV lesion may or may not show disease activity (i.e., IRF/SRF), but it is deemed visually insignificant given the underlying disciform scar. Defining inactive CNV (H35.2x2) and inactive scar (H35.2x3) in wet AMD.
When you use the codes for dry AMD (H35.31xx) and wet AMD (H35.32xx), you must use the sixth character to indicate laterality as follows:
The codes for dry AMD—H35.31xx—use the seventh character to indicate staging as follows:
When is the retina considered atrophic? The Academy Preferred Practice Pattern1 defines GA as follows:
The Academy recommends that when coding, you indicate whether the GA involves the center of the fovea: Code H35.31x4 if it does and H35.31x3 if it doesn’t, with “x” indicating laterality.
The codes for wet AMD—H35.32xx—use the sixth character to indicate laterality and the seventh character to indicate staging as follows:
Introduction to Physician Payment Policy (Sym12). A panel will explain how new CPT codes are created and valued; how existing codes are targeted for reevaluation; the impact of new technology on the valuation of existing procedures; and the difference between CMS and commercial carrier coverage policies. When: Sunday, Nov. 12, 11:15 a.m.-12:15 p.m.